Skip to main content

Table 1 Population characteristics, n= 34

From: Effect of antivenom therapy of Rhabdophis tigrinus (Yamakagashi snake) bites

Population characteristics

Values

Age (years)

37.5 (43.8)

Gender, male, n (%)

33 (97.1)

Date of getting injury (year)

 

1973–1999

25 (73.5)

2000–2013

9 (26.5)

Clinical symptoms

 

Nasal bleeding, n (%)

4 (11.8)

Gum bleeding, n (%)

15 (44.1)

Bleeding from the bite sites, n (%)

27 (79.4)

Headache, n (%)

6 (17.6)

Laboratory data

 

Platelet counts (×104/mm3)

10.7 (10.4)

Fibrinogen (mg/dL)

35 (30)

PT-INR

5 (4.38)

FDP (μg/mL)

200 (180)

DIC score

5(3)

Treatment

 

Heparin, n (%)

14 (41.2)

FFP, n (%)

8 (25.0)

PE, n (%)

4 (11.8)

Antivenom, n (%)

19 (55.9)

Time interval between getting Yamakagashi bites and antivenom administration (h)

32 (31)

Severe adverse effects related to antivenom

0 (0)

Outcome

 

Mortality, n (%)

4 (11.8)

Hospital stay

9.5 (9.5)

Renal failure requiring hemodialysis, n (%)

7 (20.6)

  1. Data are presented as median (interquartile, IQR) for continuous variables and n (percentage) for categorical variables. PT-INR prothrombin time international ratio, FDP fibrinogen degradation products, DIC disseminated intravascular coagulation, FFP fresh frozen plasma, PE plasma exchange, SD standard deviation.